Global In-Vitro Fertilization (IVF) services Market

In-Vitro Fertilization (IVF) services Comprehensive Study by Cycle Type (Donor Egg IVF Cycles, Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor)), End User (Hospitals, Fertility Clinics, Surgical Centers, Clinical Research Institutes) Players and Region - Global Market Outlook to 2028

In-Vitro Fertilization (IVF) services Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global In-Vitro Fertilization (IVF) services Market Overview:
In-vitro fertilization (IVF) is a medical procedure that involves retrieving eggs from a woman's ovaries, fertilizing them with sperm in a laboratory, and then transferring the resulting embryos into the woman's uterus. IVF is a commonly used treatment for infertility, and its global market is expected to grow significantly in the coming years due to factors such as rising infertility rates, increasing trends in delayed pregnancies, improving IVF success rates, and rising disposable incomes worldwide. However, high costs and complications associated with IVF treatment, along with low awareness of IVF in underdeveloped regions, may hinder market growth. Conversely, rising fertility tourism, an increasing number of fertility clinics, and lower costs of IVF services in developing countries compared to developed countries are expected to offer promising opportunities for market expansion.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility

Competitive Landscape:

Some of the key players profiled in the report are Merck KGaA (Germany), Bayer AG (Germany), CooperSurgical Fertility and Genomics, Inc. (United States), FUJIFILM Irvine Scientific, Inc. (United States), Vitrolife AB (Sweden), ORIGIO (Denmark), ASKA Pharmaceutical Co., Ltd. (Japan), Ferring Pharmaceuticals (Switzerland), GENOMEDICSA (Spain) and The Center for Reproductive Health (United States). Additionally, following companies can also be profiled that are part of our coverage like Igenomix (Spain), Progyny, Inc. (United States), ReproMed Systems, Inc. (United States), Boston IVF (United States) and Pacific Fertility Center (United States). Considering Market by , the sub-segment i.e. will boost the In-Vitro Fertilization (IVF) services market.

What Can be Explored with the In-Vitro Fertilization (IVF) services Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global In-Vitro Fertilization (IVF) services Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in In-Vitro Fertilization (IVF) services
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global In-Vitro Fertilization (IVF) services market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in In-Vitro Fertilization (IVF) services market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Cycle Type
  • Donor Egg IVF Cycles
  • Fresh IVF Cycles (Non-donor)
  • Thawed IVF Cycles (Non-donor)

By End User
  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Clinical Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global In-Vitro Fertilization (IVF) services, by Cycle Type, End User and Region (value) (2017-2022)
    • 4.1. Introduction
    • 4.2. Global In-Vitro Fertilization (IVF) services (Value)
      • 4.2.1. Global In-Vitro Fertilization (IVF) services by: Cycle Type (Value)
        • 4.2.1.1. Donor Egg IVF Cycles
        • 4.2.1.2. Fresh IVF Cycles (Non-donor)
        • 4.2.1.3. Thawed IVF Cycles (Non-donor)
      • 4.2.2. Global In-Vitro Fertilization (IVF) services by: End User (Value)
        • 4.2.2.1. Hospitals
        • 4.2.2.2. Fertility Clinics
        • 4.2.2.3. Surgical Centers
        • 4.2.2.4. Clinical Research Institutes
      • 4.2.3. Global In-Vitro Fertilization (IVF) services Region
        • 4.2.3.1. South America
          • 4.2.3.1.1. Brazil
          • 4.2.3.1.2. Argentina
          • 4.2.3.1.3. Rest of South America
        • 4.2.3.2. Asia Pacific
          • 4.2.3.2.1. China
          • 4.2.3.2.2. Japan
          • 4.2.3.2.3. India
          • 4.2.3.2.4. South Korea
          • 4.2.3.2.5. Taiwan
          • 4.2.3.2.6. Australia
          • 4.2.3.2.7. Rest of Asia-Pacific
        • 4.2.3.3. Europe
          • 4.2.3.3.1. Germany
          • 4.2.3.3.2. France
          • 4.2.3.3.3. Italy
          • 4.2.3.3.4. United Kingdom
          • 4.2.3.3.5. Netherlands
          • 4.2.3.3.6. Rest of Europe
        • 4.2.3.4. MEA
          • 4.2.3.4.1. Middle East
          • 4.2.3.4.2. Africa
        • 4.2.3.5. North America
          • 4.2.3.5.1. United States
          • 4.2.3.5.2. Canada
          • 4.2.3.5.3. Mexico
  • 5. In-Vitro Fertilization (IVF) services: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2022)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Merck KGaA (Germany)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Bayer AG (Germany)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. CooperSurgical Fertility and Genomics, Inc. (United States)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. FUJIFILM Irvine Scientific, Inc. (United States)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. Vitrolife AB (Sweden)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. ORIGIO (Denmark)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. ASKA Pharmaceutical Co., Ltd. (Japan)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. Ferring Pharmaceuticals (Switzerland)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. GENOMEDICSA (Spain)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. The Center for Reproductive Health (United States)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
  • 6. Global In-Vitro Fertilization (IVF) services Sale, by Cycle Type, End User and Region (value) (2023-2028)
    • 6.1. Introduction
    • 6.2. Global In-Vitro Fertilization (IVF) services (Value)
      • 6.2.1. Global In-Vitro Fertilization (IVF) services by: Cycle Type (Value)
        • 6.2.1.1. Donor Egg IVF Cycles
        • 6.2.1.2. Fresh IVF Cycles (Non-donor)
        • 6.2.1.3. Thawed IVF Cycles (Non-donor)
      • 6.2.2. Global In-Vitro Fertilization (IVF) services by: End User (Value)
        • 6.2.2.1. Hospitals
        • 6.2.2.2. Fertility Clinics
        • 6.2.2.3. Surgical Centers
        • 6.2.2.4. Clinical Research Institutes
      • 6.2.3. Global In-Vitro Fertilization (IVF) services Region
        • 6.2.3.1. South America
          • 6.2.3.1.1. Brazil
          • 6.2.3.1.2. Argentina
          • 6.2.3.1.3. Rest of South America
        • 6.2.3.2. Asia Pacific
          • 6.2.3.2.1. China
          • 6.2.3.2.2. Japan
          • 6.2.3.2.3. India
          • 6.2.3.2.4. South Korea
          • 6.2.3.2.5. Taiwan
          • 6.2.3.2.6. Australia
          • 6.2.3.2.7. Rest of Asia-Pacific
        • 6.2.3.3. Europe
          • 6.2.3.3.1. Germany
          • 6.2.3.3.2. France
          • 6.2.3.3.3. Italy
          • 6.2.3.3.4. United Kingdom
          • 6.2.3.3.5. Netherlands
          • 6.2.3.3.6. Rest of Europe
        • 6.2.3.4. MEA
          • 6.2.3.4.1. Middle East
          • 6.2.3.4.2. Africa
        • 6.2.3.5. North America
          • 6.2.3.5.1. United States
          • 6.2.3.5.2. Canada
          • 6.2.3.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. In-Vitro Fertilization (IVF) services: by Cycle Type(USD Million)
  • Table 2. In-Vitro Fertilization (IVF) services Donor Egg IVF Cycles , by Region USD Million (2017-2022)
  • Table 3. In-Vitro Fertilization (IVF) services Fresh IVF Cycles (Non-donor) , by Region USD Million (2017-2022)
  • Table 4. In-Vitro Fertilization (IVF) services Thawed IVF Cycles (Non-donor) , by Region USD Million (2017-2022)
  • Table 5. In-Vitro Fertilization (IVF) services: by End User(USD Million)
  • Table 6. In-Vitro Fertilization (IVF) services Hospitals , by Region USD Million (2017-2022)
  • Table 7. In-Vitro Fertilization (IVF) services Fertility Clinics , by Region USD Million (2017-2022)
  • Table 8. In-Vitro Fertilization (IVF) services Surgical Centers , by Region USD Million (2017-2022)
  • Table 9. In-Vitro Fertilization (IVF) services Clinical Research Institutes , by Region USD Million (2017-2022)
  • Table 10. South America In-Vitro Fertilization (IVF) services, by Country USD Million (2017-2022)
  • Table 11. South America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 12. South America In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 13. Brazil In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 14. Brazil In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 15. Argentina In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 16. Argentina In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 17. Rest of South America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 18. Rest of South America In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 19. Asia Pacific In-Vitro Fertilization (IVF) services, by Country USD Million (2017-2022)
  • Table 20. Asia Pacific In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 21. Asia Pacific In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 22. China In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 23. China In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 24. Japan In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 25. Japan In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 26. India In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 27. India In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 28. South Korea In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 29. South Korea In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 30. Taiwan In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 31. Taiwan In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 32. Australia In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 33. Australia In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 34. Rest of Asia-Pacific In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 35. Rest of Asia-Pacific In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 36. Europe In-Vitro Fertilization (IVF) services, by Country USD Million (2017-2022)
  • Table 37. Europe In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 38. Europe In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 39. Germany In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 40. Germany In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 41. France In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 42. France In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 43. Italy In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 44. Italy In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 45. United Kingdom In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 46. United Kingdom In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 47. Netherlands In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 48. Netherlands In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 49. Rest of Europe In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 50. Rest of Europe In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 51. MEA In-Vitro Fertilization (IVF) services, by Country USD Million (2017-2022)
  • Table 52. MEA In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 53. MEA In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 54. Middle East In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 55. Middle East In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 56. Africa In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 57. Africa In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 58. North America In-Vitro Fertilization (IVF) services, by Country USD Million (2017-2022)
  • Table 59. North America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 60. North America In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 61. United States In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 62. United States In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 63. Canada In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 64. Canada In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 65. Mexico In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2017-2022)
  • Table 66. Mexico In-Vitro Fertilization (IVF) services, by End User USD Million (2017-2022)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. In-Vitro Fertilization (IVF) services: by Cycle Type(USD Million)
  • Table 78. In-Vitro Fertilization (IVF) services Donor Egg IVF Cycles , by Region USD Million (2023-2028)
  • Table 79. In-Vitro Fertilization (IVF) services Fresh IVF Cycles (Non-donor) , by Region USD Million (2023-2028)
  • Table 80. In-Vitro Fertilization (IVF) services Thawed IVF Cycles (Non-donor) , by Region USD Million (2023-2028)
  • Table 81. In-Vitro Fertilization (IVF) services: by End User(USD Million)
  • Table 82. In-Vitro Fertilization (IVF) services Hospitals , by Region USD Million (2023-2028)
  • Table 83. In-Vitro Fertilization (IVF) services Fertility Clinics , by Region USD Million (2023-2028)
  • Table 84. In-Vitro Fertilization (IVF) services Surgical Centers , by Region USD Million (2023-2028)
  • Table 85. In-Vitro Fertilization (IVF) services Clinical Research Institutes , by Region USD Million (2023-2028)
  • Table 86. South America In-Vitro Fertilization (IVF) services, by Country USD Million (2023-2028)
  • Table 87. South America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 88. South America In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 89. Brazil In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 90. Brazil In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 91. Argentina In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 92. Argentina In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 93. Rest of South America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 94. Rest of South America In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 95. Asia Pacific In-Vitro Fertilization (IVF) services, by Country USD Million (2023-2028)
  • Table 96. Asia Pacific In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 97. Asia Pacific In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 98. China In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 99. China In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 100. Japan In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 101. Japan In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 102. India In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 103. India In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 104. South Korea In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 105. South Korea In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 106. Taiwan In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 107. Taiwan In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 108. Australia In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 109. Australia In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 110. Rest of Asia-Pacific In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 111. Rest of Asia-Pacific In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 112. Europe In-Vitro Fertilization (IVF) services, by Country USD Million (2023-2028)
  • Table 113. Europe In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 114. Europe In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 115. Germany In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 116. Germany In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 117. France In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 118. France In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 119. Italy In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 120. Italy In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 121. United Kingdom In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 122. United Kingdom In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 123. Netherlands In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 124. Netherlands In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 125. Rest of Europe In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 126. Rest of Europe In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 127. MEA In-Vitro Fertilization (IVF) services, by Country USD Million (2023-2028)
  • Table 128. MEA In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 129. MEA In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 130. Middle East In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 131. Middle East In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 132. Africa In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 133. Africa In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 134. North America In-Vitro Fertilization (IVF) services, by Country USD Million (2023-2028)
  • Table 135. North America In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 136. North America In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 137. United States In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 138. United States In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 139. Canada In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 140. Canada In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 141. Mexico In-Vitro Fertilization (IVF) services, by Cycle Type USD Million (2023-2028)
  • Table 142. Mexico In-Vitro Fertilization (IVF) services, by End User USD Million (2023-2028)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global In-Vitro Fertilization (IVF) services: by Cycle Type USD Million (2017-2022)
  • Figure 5. Global In-Vitro Fertilization (IVF) services: by End User USD Million (2017-2022)
  • Figure 6. South America In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 7. Asia Pacific In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 8. Europe In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 9. MEA In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 10. North America In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 11. Global In-Vitro Fertilization (IVF) services share by Players 2022 (%)
  • Figure 12. Global In-Vitro Fertilization (IVF) services share by Players (Top 3) 2022(%)
  • Figure 13. Global In-Vitro Fertilization (IVF) services share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 17. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Bayer AG (Germany) Revenue: by Geography 2022
  • Figure 19. CooperSurgical Fertility and Genomics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. CooperSurgical Fertility and Genomics, Inc. (United States) Revenue: by Geography 2022
  • Figure 21. FUJIFILM Irvine Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. FUJIFILM Irvine Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Vitrolife AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 24. Vitrolife AB (Sweden) Revenue: by Geography 2022
  • Figure 25. ORIGIO (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. ORIGIO (Denmark) Revenue: by Geography 2022
  • Figure 27. ASKA Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 28. ASKA Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2022
  • Figure 29. Ferring Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Ferring Pharmaceuticals (Switzerland) Revenue: by Geography 2022
  • Figure 31. GENOMEDICSA (Spain) Revenue, Net Income and Gross profit
  • Figure 32. GENOMEDICSA (Spain) Revenue: by Geography 2022
  • Figure 33. The Center for Reproductive Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. The Center for Reproductive Health (United States) Revenue: by Geography 2022
  • Figure 35. Global In-Vitro Fertilization (IVF) services: by Cycle Type USD Million (2023-2028)
  • Figure 36. Global In-Vitro Fertilization (IVF) services: by End User USD Million (2023-2028)
  • Figure 37. South America In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 38. Asia Pacific In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 39. Europe In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 40. MEA In-Vitro Fertilization (IVF) services Share (%), by Country
  • Figure 41. North America In-Vitro Fertilization (IVF) services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck KGaA (Germany)
  • Bayer AG (Germany)
  • CooperSurgical Fertility and Genomics, Inc. (United States)
  • FUJIFILM Irvine Scientific, Inc. (United States)
  • Vitrolife AB (Sweden)
  • ORIGIO (Denmark)
  • ASKA Pharmaceutical Co., Ltd. (Japan)
  • Ferring Pharmaceuticals (Switzerland)
  • GENOMEDICSA (Spain)
  • The Center for Reproductive Health (United States)
Additional players considered in the study are as follows:
Igenomix (Spain) , Progyny, Inc. (United States) , ReproMed Systems, Inc. (United States) , Boston IVF (United States) , Pacific Fertility Center (United States)
Select User Access Type

Key Highlights of Report


Nov 2023 208 Pages 77 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global In-Vitro Fertilization (IVF) services Market Quantitative research analysis
Global In-Vitro Fertilization (IVF) services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global In-Vitro Fertilization (IVF) services market are Merck KGaA (Germany), Bayer AG (Germany), CooperSurgical Fertility and Genomics, Inc. (United States), FUJIFILM Irvine Scientific, Inc. (United States), Vitrolife AB (Sweden), ORIGIO (Denmark), ASKA Pharmaceutical Co., Ltd. (Japan), Ferring Pharmaceuticals (Switzerland), GENOMEDICSA (Spain) and The Center for Reproductive Health (United States), to name a few.
"" is seen as one of major influencing trends for In-Vitro Fertilization (IVF) services Market during projected period 2022-2028.

Know More About Global In-Vitro Fertilization (IVF) services Market Report?

Have a Query? Click Here

Other Related Reports

Updated Load Balancing Tools Comprehensive Study by Type (Global Load Balancer, Local Load Balancer), Services (Training and Consulting, Support and Maintenance, Integration and Deployment), Organiza...
$ 3800
Mission Critical Communication (MCX)- Comprehensive Study by Application (Voice Communication, Data Transmission, Video Surveillance, Location Services, Dispatch and Control Centers, Others), Deploym...
$ 3990
Stock Music Industry Depth Comprehensive Study by Type (Royalty Free Music, Right Managed Music), Application (Film, Television, Radio, Advertising, Creators, Gaming, Others), End Users (Large Enterp...
$ 3800
United States Kitchen and Lavatory Faucets (inclusive of tub shower) and Bath Accessories Comprehensive Study by Type (Kitchen Faucets, Specialty Faucets, Kitchen Accessories, Bathroom Faucets, Tub &...
$ 3800
Canada Kitchen and Lavatory Faucets (inclusive of tub shower) and Bath Accessories Comprehensive Study by Type (Kitchen Faucets, Specialty Faucets, Kitchen Accessories, Bathroom Faucets, Tub & Shower...
$ 3800
Polyurethane Coatings Comprehensive Study by Type (Water borne, Solvent Borne, High Solids, Powder coating, Others), Application (Spray, Roller, Brush), End Users (Aerospace, Automotive, Construction...
$ 3800